INARI MEDICAL INC. - COMMON STOCK

79,93

13-февраля-25 16:45:00

15 мин. задержка

Акции

+0,01

+0,01%

Сегодняшний диапазон

79,91 - 79,95

ISIN

N/A

Источник

NASDAQ

Inari Medical to Announce First Quarter 2023 Financial Results

13 апр 2023 16:01:00 Источник Nasdaq GlobeNewswire
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

06 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

27 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

07 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

31 янв 2023 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

12 янв 2023 08:00:00 Источник Nasdaq GlobeNewswire
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

10 янв 2023 08:00:01 Источник Nasdaq GlobeNewswire
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

21 дек 2022 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

03 ноя 2022 16:01:01 Источник Nasdaq GlobeNewswire
Inari Medical Reports Third Quarter 2022 Financial Results

02 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
Inari Medical Announces In-hospital and 30-day Outcomes from the Fully Enrolled CLOUT Registry and Results from Propensity-Score Matched Comparison of CLOUT vs. ATTRACT

31 окт 2022 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical to Announce Third Quarter 2022 Financial Results

06 окт 2022 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical Announces Results from the Fully Enrolled 800-patient US Cohort of the FlowTriever FLASH Registry

19 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire
Inari Medical to Host First Analyst & Investor Day

02 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical Announces Three New Data Sets to be Presented During Late-Breaking Clinical Trial Sessions at the 2022 TCT and VEINS Conferences

01 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

30 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire
Inari Medical to Present at Upcoming Investor Conferences

25 авг 2022 16:36:00 Источник Nasdaq GlobeNewswire
Inari Medical Announces Leadership Succession Plan

03 авг 2022 16:06:00 Источник Nasdaq GlobeNewswire
Inari Medical Reports Second Quarter 2022 Financial Results

03 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire
Inari Medical to Announce Second Quarter 2022 Financial Results

18 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.